Covered recipient · General Payments record
AMY M TRAYLOR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$608.33
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $394.53 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $162.86 | 14 |
| Acerta Pharma LLC | $57.20 | 3 |
| Amgen Inc. | $40.88 | 3 |
| Lilly USA, LLC | $32.38 | 2 |
| Novo Nordisk AS | $30.15 | 2 |
| Supernus Pharmaceuticals, Inc. | $24.93 | 1 |
| PFIZER INC. | $16.29 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.97 | 1 |
| GlaxoSmithKline, LLC. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.84 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241492 | CMS |
| ABBVIE INC. | $18.70 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241494 | CMS |
| ABBVIE INC. | $16.51 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241496 | CMS |
| ABBVIE INC. | $6.51 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241498 | CMS |
| ABBVIE INC. | $18.59 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241500 | CMS |
| ABBVIE INC. | $4.29 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241502 | CMS |
| ABBVIE INC. | $10.87 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241504 | CMS |
| ABBVIE INC. | $3.09 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241506 | CMS |
| ABBVIE INC. | $14.73 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241508 | CMS |
| ABBVIE INC. | $26.63 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241510 | CMS |
| ABBVIE INC. | $11.59 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241512 | CMS |
| ABBVIE INC. | $7.10 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241514 | CMS |
| ABBVIE INC. | $11.75 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241516 | CMS |
| ABBVIE INC. | $8.66 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106241518 | CMS |
| Amgen Inc. | $13.52 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117401622 | CMS |
| Amgen Inc. | $13.08 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117401624 | CMS |
| Amgen Inc. | $14.28 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117401626 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.32 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105768684 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.72 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104227723 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.16 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105708580 | CMS |
| GlaxoSmithKline, LLC. | $13.87 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116669518 | CMS |
| Lilly USA, LLC | $13.94 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135997889 | CMS |
| Lilly USA, LLC | $18.44 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135997887 | CMS |
| Novo Nordisk Inc | $16.95 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097537122 | CMS |
| Novo Nordisk Inc | $13.20 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097731825 | CMS |
| PFIZER INC. | $16.29 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131884785 | CMS |
| Supernus Pharmaceuticals, Inc. | $24.93 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147885420 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.97 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137689004 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.